Cleared Traditional

K832767 - ADVANTAGE #1700

K832767 is an FDA 510(k) clearance for ADVANTAGE #1700, manufactured by The Perkin-Elmer Corp.. The device is a Class 2 Anesthesiology device with product code CCK cleared through the Traditional 510(k) pathway after a 79-day FDA review.

K832767 · The Perkin-Elmer Corp. · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 1983
Decision
79d
Days
Class 2
Risk

K832767 is an FDA 510(k) clearance for the ADVANTAGE #1700. Classified as Analyzer, Gas, Carbon-dioxide, Gaseous-phase (product code CCK), Class II - Special Controls.

Submitted by The Perkin-Elmer Corp. (Mchenry, US). The FDA issued a Cleared decision on November 3, 1983 after a review of 79 days - a notably fast clearance cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.1400 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all The Perkin-Elmer Corp. devices

FDA 510(k) Submission Details - K832767

510(k) Number K832767 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 16, 1983
Decision Date November 03, 1983
Days to Decision 79 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
61d faster than avg
Panel avg: 140d · This submission: 79d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CCK Device Classification - Class 2, Special Controls

Product Code CCK Analyzer, Gas, Carbon-dioxide, Gaseous-phase
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.1400
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CCK Analyzer, Gas, Carbon-dioxide, Gaseous-phase

All 151
Devices cleared under the same product code (CCK) and FDA review panel - the closest regulatory comparables to K832767.
C02 MONITOR-OIR-7101
K841498 · Nihon Kohden America, Inc. · May 1984
TRI-MED 511 INFANT RESPIRATION MONITOR
K833397 · Tri-Med, Inc. · Nov 1983
CAPNOMETER W/NEW AIRWAY ADAPTER 47210A
K831447 · Hewlett-Packard Co. · Nov 1983
CAPNOGRAPH
K831776 · Datascope Corp. · Oct 1983
ENGSTROM ELIZA CO2 ANALYZER
K823049 · Lkb Instruments, Inc. · Jan 1983
LIFESPAN CO2
K812643 · Biochem International, Inc. · Nov 1981